PMID- 12124561 OWN - NLM STAT- MEDLINE DCOM- 20021029 LR - 20161026 IS - 0021-9509 (Print) IS - 0021-9509 (Linking) VI - 43 IP - 4 DP - 2002 Aug TI - Low molecular weight heparins in the long-term treatment of venous thromboembolism. PG - 495-500 AB - Low molecular weight heparins (LMWHs) have extensively replaced unfractionated heparin (UFH) in both thromboprophylaxis and initial treatment of venous thromboembolism (VTE) and their use for such indications is now well established. This paper reviews the role of LMWHs in the long-term treatment of VTE. Venous thrombosis, although a very frequent occurrence in everyday practice, still remains controversial in its treatment. Available literature comparing different LMWHs with UFH and oral anticoagulants (OAs) is presented. Comparison and evaluation of the effectiveness, safety and costs of alternative treatments are also made. The differences of various LMWHs are discussed and the need for separate clinical trials for every single LMWH is highlighted. FAU - Liapis, C D AU - Liapis CD AD - 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko Hospital, Greece. FAU - Daskalopoulos, M E AU - Daskalopoulos ME FAU - Daskalopoulou, S E AU - Daskalopoulou SE LA - eng PT - Journal Article PT - Review PL - Italy TA - J Cardiovasc Surg (Torino) JT - The Journal of cardiovascular surgery JID - 0066127 RN - 0 (Anticoagulants) RN - 0 (Heparin, Low-Molecular-Weight) RN - 9005-49-6 (Heparin) SB - IM MH - Anticoagulants/therapeutic use MH - Heparin/therapeutic use MH - Heparin, Low-Molecular-Weight/*therapeutic use MH - Humans MH - Thromboembolism/*drug therapy MH - Time Factors MH - Venous Thrombosis/*drug therapy RF - 60 EDAT- 2002/07/19 10:00 MHDA- 2002/10/31 04:00 CRDT- 2002/07/19 10:00 PHST- 2002/07/19 10:00 [pubmed] PHST- 2002/10/31 04:00 [medline] PHST- 2002/07/19 10:00 [entrez] PST - ppublish SO - J Cardiovasc Surg (Torino). 2002 Aug;43(4):495-500.